{"id":63713,"date":"2026-01-19T23:00:58","date_gmt":"2026-01-20T04:00:58","guid":{"rendered":"https:\/\/bnonews.com\/?p=63713"},"modified":"2026-01-19T23:49:40","modified_gmt":"2026-01-20T04:49:40","slug":"glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering","status":"publish","type":"post","link":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/","title":{"rendered":"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering"},"content":{"rendered":"\n<p>GLP-1 drugs have rapidly gained a significant place in the discourse of weight loss and metabolic health. These drugs were initially designed to treat type 2 diabetes but currently they are commonly administered to aid weight control. They benefit a lot of patients. Still, physicians underline that not every patient can be treated with GLP-1. Side effects, cost, and medical limitations mean other approaches remain important. With the growing demand, clinicians are talking more about the alternatives that individuals unable or unwilling to use these drugs can opt for.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">When GLP-1 May Not Be the Right Fit<\/h2>\n\n\n\n<p><a href=\"https:\/\/www.gov.uk\/government\/publications\/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know\/glp-1-medicines-for-weight-loss-and-diabetes-what-you-need-to-know\">GLP-1 drugs<\/a> are effective in some patients but may produce nausea, vomiting, stomach pain, and fatigue, especially during the first phase of treatment. For others, the issue is medical eligibility. People with certain thyroid conditions, a history of pancreatitis, or those who are pregnant are often advised against using them.<\/p>\n\n\n\n<p>Access also matters. The expensive price, insurance limitations, and supply shortages have made patients and physicians re-examine the long-term use of one type of drug. These issues have resparked interest in <a href=\"https:\/\/www.tryshed.com\/blog\/doctors-notes-exploring-alternative-medications-to-glp-1s\">alternatives to GLP1<\/a> that might provide safer or easier avenues to some people.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Lifestyle Changes Still Form the Foundation<\/h2>\n\n\n\n<p>Although there is progress in medication, the majority of physicians concur that long-term health revolves around lifestyle-based interventions. Whole-foods, high-protein, and stable blood sugar nutrition plans are usually prescribed.&nbsp;&nbsp;<\/p>\n\n\n\n<p>Regular movement is also essential. This does not always imply vigorous exercise. Structured physical therapy helps improve mobility, alleviate pain, as well as enable regular activity in some patients. Minor, long-term adjustments tend to yield greater success than short-term plans.<\/p>\n\n\n\n<p>Another acute aspect is behavioral support. Patients who have weight issues linked to stress, sleep or other emotional issues can develop lifelong habits with counseling and structured programs.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Medications That Don\u2019t Target GLP-1<\/h2>\n\n\n\n<p>Doctors may also consider other FDA-approved medications that work through different biological pathways. Some decrease appetite by acting on the central nervous system, whilst others augment insulin sensitivity or reduce fat uptake. These medications usually have a less significant effect than GLP-1 treatments, yet they may be efficient upon a careful prescription.<\/p>\n\n\n\n<p>Notably, these drugs are not interchangeable. They have their respective risk profile, side effects and appropriateness based on the health history of a patient. This is the reason why supervision and follow-up are critical during the administration of treatment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">New Therapies on the Horizon<\/h2>\n\n\n\n<p>Studies on metabolic health are progressing quickly. Researchers are looking into novel gut hormones, combination medicines and remedies that act on several routes of hunger and energy regulation. Pilot testing indicates that new therapies can provide similar benefits as GLP-1 drugs. That too with fewer side effects.<\/p>\n\n\n\n<p>Physicians are wary, though. The majority of these new treatments can take years to be tested and become common. Up till that point, they are alternatives to be observed and not solutions to use immediately.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Surgical and Procedural Options<\/h2>\n\n\n\n<p>Patients with severe obesity or obesity-related complications are often advised to undergo surgical procedures like bariatric surgery. These long-established procedures can result in considerable and permanent weight loss when combined with lifestyle change.<\/p>\n\n\n\n<p>Less invasive medical procedures are also being explored, though many are still under evaluation. Like medicines, physicians take time to evaluate risks, advantages, and willingness of the patient before proposing such alternatives.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Making Informed Health Choices<\/h2>\n\n\n\n<p>Finally, specialists emphasize that no universal solution can apply to all people. Treatment relies on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Individual medical history<\/li>\n\n\n\n<li>Access to treatment\u00a0<\/li>\n\n\n\n<li>Long-term objectives<\/li>\n<\/ul>\n\n\n\n<p>Patients should have informed discussions with healthcare providers to come up with effective <a href=\"https:\/\/bnonews.com\/index.php\/2026\/01\/how-social-media-is-influencing-mens-health-decisions\/\">health decisions<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Endnote&nbsp;<\/h2>\n\n\n\n<p>GLP-1 medications have transformed the landscape of treatment, but they are only one of the tools. With the growing research and available choices, personalized care remains the guiding principle.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>GLP-1 drugs have rapidly gained a significant place in the discourse of weight loss and metabolic health. These drugs were initially designed to treat type 2 diabetes but currently they are commonly administered to aid weight control. They benefit a lot of patients. Still, physicians underline that not every patient can be treated with GLP-1. [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":63714,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[2405,60],"tags":[],"class_list":["post-63713","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-reviews","category-unlisted"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering - BNO News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering - BNO News\" \/>\n<meta property=\"og:description\" content=\"GLP-1 drugs have rapidly gained a significant place in the discourse of weight loss and metabolic health. These drugs were initially designed to treat type 2 diabetes but currently they are commonly administered to aid weight control. They benefit a lot of patients. Still, physicians underline that not every patient can be treated with GLP-1. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\" \/>\n<meta property=\"og:site_name\" content=\"BNO News\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/bnonews\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-20T04:00:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T04:49:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"659\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Contributor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@bnonews\" \/>\n<meta name=\"twitter:site\" content=\"@bnonews\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Contributor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\"},\"author\":{\"name\":\"Contributor\",\"@id\":\"https:\/\/bnonews.com\/#\/schema\/person\/e3952aff283010ff6ff362dc8c40b981\"},\"headline\":\"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering\",\"datePublished\":\"2026-01-20T04:00:58+00:00\",\"dateModified\":\"2026-01-20T04:49:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\"},\"wordCount\":633,\"publisher\":{\"@id\":\"https:\/\/bnonews.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg\",\"articleSection\":[\"Reviews\",\"unlisted\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\",\"url\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\",\"name\":\"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering - BNO News\",\"isPartOf\":{\"@id\":\"https:\/\/bnonews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg\",\"datePublished\":\"2026-01-20T04:00:58+00:00\",\"dateModified\":\"2026-01-20T04:49:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage\",\"url\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg\",\"contentUrl\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg\",\"width\":1024,\"height\":659},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bnonews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/bnonews.com\/#website\",\"url\":\"https:\/\/bnonews.com\/\",\"name\":\"BNO News\",\"description\":\"Breaking news and developing stories from the U.S. and around the world\",\"publisher\":{\"@id\":\"https:\/\/bnonews.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/bnonews.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/bnonews.com\/#organization\",\"name\":\"BNO News\",\"url\":\"https:\/\/bnonews.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bnonews.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2018\/03\/BNOLOGOTV.png\",\"contentUrl\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2018\/03\/BNOLOGOTV.png\",\"width\":1696,\"height\":1443,\"caption\":\"BNO News\"},\"image\":{\"@id\":\"https:\/\/bnonews.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"http:\/\/www.facebook.com\/bnonews\/\",\"https:\/\/x.com\/bnonews\",\"http:\/\/www.instagram.com\/bnonews\/\",\"http:\/\/www.linkedin.com\/company\/bno-news\",\"http:\/\/www.pinterest.com\/bnonewstv\/\",\"http:\/\/www.youtube.com\/bnonews\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/bnonews.com\/#\/schema\/person\/e3952aff283010ff6ff362dc8c40b981\",\"name\":\"Contributor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/bnonews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2024\/04\/writer-blogger-author-icon-150x150.png\",\"contentUrl\":\"https:\/\/bnonews.com\/wp-content\/uploads\/2024\/04\/writer-blogger-author-icon-150x150.png\",\"caption\":\"Contributor\"},\"url\":\"https:\/\/bnonews.com\/index.php\/author\/contributor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering - BNO News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/","og_locale":"en_US","og_type":"article","og_title":"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering - BNO News","og_description":"GLP-1 drugs have rapidly gained a significant place in the discourse of weight loss and metabolic health. These drugs were initially designed to treat type 2 diabetes but currently they are commonly administered to aid weight control. They benefit a lot of patients. Still, physicians underline that not every patient can be treated with GLP-1. [&hellip;]","og_url":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/","og_site_name":"BNO News","article_publisher":"http:\/\/www.facebook.com\/bnonews\/","article_published_time":"2026-01-20T04:00:58+00:00","article_modified_time":"2026-01-20T04:49:40+00:00","og_image":[{"width":1024,"height":659,"url":"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg","type":"image\/jpeg"}],"author":"Contributor","twitter_card":"summary_large_image","twitter_creator":"@bnonews","twitter_site":"@bnonews","twitter_misc":{"Written by":"Contributor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#article","isPartOf":{"@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/"},"author":{"name":"Contributor","@id":"https:\/\/bnonews.com\/#\/schema\/person\/e3952aff283010ff6ff362dc8c40b981"},"headline":"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering","datePublished":"2026-01-20T04:00:58+00:00","dateModified":"2026-01-20T04:49:40+00:00","mainEntityOfPage":{"@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/"},"wordCount":633,"publisher":{"@id":"https:\/\/bnonews.com\/#organization"},"image":{"@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage"},"thumbnailUrl":"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg","articleSection":["Reviews","unlisted"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/","url":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/","name":"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering - BNO News","isPartOf":{"@id":"https:\/\/bnonews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage"},"image":{"@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage"},"thumbnailUrl":"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg","datePublished":"2026-01-20T04:00:58+00:00","dateModified":"2026-01-20T04:49:40+00:00","breadcrumb":{"@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#primaryimage","url":"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg","contentUrl":"https:\/\/bnonews.com\/wp-content\/uploads\/2026\/01\/2017Doctor.jpg","width":1024,"height":659},{"@type":"BreadcrumbList","@id":"https:\/\/bnonews.com\/index.php\/2026\/01\/glp-1-isnt-for-everyone-heres-what-else-doctors-are-considering\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bnonews.com\/"},{"@type":"ListItem","position":2,"name":"GLP-1 Isn\u2019t for Everyone: Here\u2019s What Else Doctors Are Considering"}]},{"@type":"WebSite","@id":"https:\/\/bnonews.com\/#website","url":"https:\/\/bnonews.com\/","name":"BNO News","description":"Breaking news and developing stories from the U.S. and around the world","publisher":{"@id":"https:\/\/bnonews.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/bnonews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/bnonews.com\/#organization","name":"BNO News","url":"https:\/\/bnonews.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bnonews.com\/#\/schema\/logo\/image\/","url":"https:\/\/bnonews.com\/wp-content\/uploads\/2018\/03\/BNOLOGOTV.png","contentUrl":"https:\/\/bnonews.com\/wp-content\/uploads\/2018\/03\/BNOLOGOTV.png","width":1696,"height":1443,"caption":"BNO News"},"image":{"@id":"https:\/\/bnonews.com\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/bnonews\/","https:\/\/x.com\/bnonews","http:\/\/www.instagram.com\/bnonews\/","http:\/\/www.linkedin.com\/company\/bno-news","http:\/\/www.pinterest.com\/bnonewstv\/","http:\/\/www.youtube.com\/bnonews"]},{"@type":"Person","@id":"https:\/\/bnonews.com\/#\/schema\/person\/e3952aff283010ff6ff362dc8c40b981","name":"Contributor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/bnonews.com\/#\/schema\/person\/image\/","url":"https:\/\/bnonews.com\/wp-content\/uploads\/2024\/04\/writer-blogger-author-icon-150x150.png","contentUrl":"https:\/\/bnonews.com\/wp-content\/uploads\/2024\/04\/writer-blogger-author-icon-150x150.png","caption":"Contributor"},"url":"https:\/\/bnonews.com\/index.php\/author\/contributor\/"}]}},"_links":{"self":[{"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/posts\/63713"}],"collection":[{"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/comments?post=63713"}],"version-history":[{"count":1,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/posts\/63713\/revisions"}],"predecessor-version":[{"id":63715,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/posts\/63713\/revisions\/63715"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/media\/63714"}],"wp:attachment":[{"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/media?parent=63713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/categories?post=63713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnonews.com\/index.php\/wp-json\/wp\/v2\/tags?post=63713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}